Reproductive Health
News on noninvasive prenatal testing, carrier screening, and preimplantation genetic screening.
Hologic Non-COVID Fiscal Q4 Dx Revenues Rise 17 Percent
The firm reported that, excluding COVID-19 testing, its molecular diagnostics business grew 15 percent and overall diagnostics business grew 11 percent.
The assay distinguishes high-grade serous ovarian cancer tumors from benign masses using cell-free DNA methylation.
Evvy Closes $14M Series A for Vaginal Microbiome Testing, Launches Add-on STI Screen
The New York-based firm will use the funds to scale access to its testing, discover new vaginal health biomarkers, and validate outcomes of its service.
New data has demonstrated that DNA fragment size differences that discriminate preeclampsia from healthy controls can be detected using a lower-cost PCR method.
Natera Launches $250M Follow-On Stock Offering at $55 Per Share
Natera is offering 4,550,000 common shares at $55 per share in the offering, which is expected to close Sept. 11, with additional shares available to the underwriters.